Apr 2, 2020
12:25:01am
12:25:01am
It would be amazing. The data is good but it is anecdotal
at this point. The FDA cannot draw conclusions from that.
BUT it is a good start. What you need is a double blind, controlled study with a scientifically large sample size. That’s the only way the FDA will move on it, and the only way doctors will see it as an actual standard of care or standard treatment
BUT it is a good start. What you need is a double blind, controlled study with a scientifically large sample size. That’s the only way the FDA will move on it, and the only way doctors will see it as an actual standard of care or standard treatment
Originally posted on Apr 2, 2020 at 12:25:01am
Message modified by macdizzle on Apr 2, 2020 at 12:30:18am
- Previous username
- mckaya
- Bio page
- macdizzle
- Joined
- Aug 31, 2010
- Last login
- Jun 19, 2024
- Total posts
- 16,461 (118 FO)
